Clinical Trial Update: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells [Phase 1]

View source ↗

Summary

Phase 1 trial of cellular therapy using mesenchymal stem cells to treat Type 1 diabetes mellitus. The study is led by the Medical University of South Carolina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: ACTIVE_NOT_RECRUITING